BioHealth News Archive
Which DC Venture Capital Firm Has the Most Klout? – InTheCapital
Washington, D.C. has become one of the centers for high-tech innovation, spurring some of the biggest investments from venture capital firms in the country.…
Read More
HIMSS Innovation Center opens its doors – Healthcare IT News
The HIMSS Innovation Center opens today in Cleveland, a city, known around the world for the Cleveland Clinic and the Rock and Roll Hall…
Read More
GSK aims to market world’s first malaria vaccine – Reuters
British drugmaker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed the shot significantly cut cases…
Read More
15-Year-Old Develops Early Detection Test for Pancreatic Cancer
Kids today ... are actually doing some amazing stuff. Take 15-year-old Jack Andraka, who recently won the grand prize of the Intel International Science…
Read More
New Enterprise Associates owns 75 percent of GlycoMimetics – Washington Business Journal
Bicoastal venture firm New Enterprise Associates owns 75.2 percent of GlycoMimetics Inc., making NEA by far the biggest beneficiary of the Gaithersburg biotech's planned…
Read More
MacroGenics slated to go public this week – Washington Business Journal
MacroGenics Inc. is slated to go public this week. The Rockville drug-maker plans to raise as much as $73.6 million to fund the development…
Read More
Neutropenic Mouse Thigh Model Now Offered by Noble Life Sciences
Noble Life Sciences (Gaithersburg, MD), in collaboration with ImQuest BioSciences (Frederick, MD), has successfully developed a neutropenic mouse thigh model of infection and demonstrated…
Read More
Darpa Courts Biotech Researchers – Government – The Chronicle of Higher Education
Donald E. Ingber, a professor at Harvard University, has combined advanced electronics and biology to create a "lung on a chip," a breakthrough device…
Read More
Glycomimetics Files Registration Statement for Proposed Initial Public Offering – GlycoMimetics
GlycoMimetics, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for the…
Read MoreHigh Blood Sugar Linked with Cancer – TeleManagement
Even people without diabetes could be at higher risk of dying from disease High blood sugar has been linked to a greater risk of…
Read More
BioMarker Strategies Appoints Jerry Parrott President and CEO – HispanicBusiness.com
BioMarker Strategies announced the appointment of Jerry Parrott as President, Chief Executive Officer and Director, effective immediately. According to a release, Parrott will report…
Read More
Fyodor Awarded SBIR Phase 2 Grant
Fyodor, a Baltimore-based biotechnology company, announced today that the US National Science Foundation (NSF) has awarded the company a Small Business Innovation Research (SBIR)…
Read More
Epigenomics AG: Epigenomics signs joint commercialization agreement for Epi proColon® in North America with Polymedco
Berlin, Germany, and U.S.A. - Epigenomics AG (Frankfurt Prime Standard: ECX, OTC: EPGNY), the German-American cancer molecular diagnostics company, announced today that it has…
Read More
New Enterprise Associates joins $10M round for drug accelerator – Washington Business Journal
Chevy Chase-based New Enterprise Associates has joined in a $10 million financing for Cydan LLC, a Cambridge, Mass.-based orphan drug accelerator. The additional funding…
Read More
Merck, J&J Back Stanford Student Incubator as Farm Team – Xconomy
A veteran biotechnology reporter once complained privately that covering the industry was like watching grass grow—companies seemed to inch by slow degrees toward products…
Read More